PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

ESICM 2023 ARDS Guideline: Definition, Phenotyping and Non-Pharmacological Respiratory Support Recommendations

ESICM ARDS guideline 2023European Society of Intensive Care Medicineacute respiratory distress syndromeacute hypoxemic respiratory failurehigh-flow nasal oxygenCPAP/NIVlow tidal volume ventilationPEEPneuromuscular blockersGRADE Critical Care / ICU

Background Information

New ARDS guidelines redefine care with phenotyping focus.

Acute respiratory distress syndrome (ARDS) management is crucial for critical care outcomes; updated guidelines influence practice globally. The guidelines provide a refined ARDS definition, emphasize phenotyping, and include new respiratory support strategies such as neuromuscular blockade. Clarifies ARDS management, possibly changing practices regarding phenotyping and respiratory strategies, but specific impact depends on local adaptation. The ESICM 2023 ARDS guidelines emphasize phenotyping and updated respiratory strategies.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.

View on PubMed →

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Founding member rate
$8/month. Cancel anytime.

One subscription unlocks this analysis and every other one we publish, plus Practice Signals, PDF reports, and GRADE evidence grades.

Subscribe for $8/month → Read this one free →
Free account, no credit card. Includes 1 full deep analysis every month.
Or $79/year. Founding members keep this rate for as long as they stay subscribed. Cancel anytime from your Account page.